As of November 2024, the (pure play) biotechnology subsector's aggregated enterprise value was estimated at some 255 billion U.S. dollars. The largest subsector was by far commercial pharma, which also includes many companies that are active in biotech. This statistic shows the aggregate enterprise value of select subsectors of the biopharma economy worldwide as of 2024.
* For commercial use only
Basic Account
Starter Account
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Everything on "Medical biotech industry" in one document: edited and divided into chapters, including detailed references.
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield
Vice President, Hearst Magazines
Global overview
Research & development
R&D country comparison
Products
Funding/M&A/IPOs
Focus: U.S. companies
* For commercial use only
Basic Account
Starter Account
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
